Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Company

    • Home
    • Company
    • Page 549
Company

China Biopharma Posts 216% Revenue Increase, Eyes US$10 Million in 2007 with Vaccine Distribution and New Treatments

Fineline Cube Apr 4, 2007

China Biopharma Corporation, trading on the OTC Bulletin Board under the symbol (CBPC.OB), announced a...

Company

India Launches Anti-Dumping Campaign Against Chinese Vitamin B12 and Ceftriaxone Sodium Producers

Fineline Cube Apr 4, 2007

In a strategic response to India’s Ministry of Commerce and Industry’s (MOFCOM) anti-dumping ruling against...

Company

Novartis Sees 15% Global Sales Growth and Significant Investment in China for 2006

Fineline Cube Apr 4, 2007

Novartis (NYSE: NVS), a multinational pharmaceutical giant, has reported a robust sales revenue of nearly...

Company

China’s Western Pharmaceutical Exports Soar 23% in 2006, Led by Antibiotics

Fineline Cube Apr 4, 2007

The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...

Posts pagination

1 … 548 549

Recent updates

  • HBM BMS Multi-Specific Antibody Deal Targets $1 Billion Milestones
  • Antengene Xpovio sNDA Malaysia Approval Expands DLBCL Indication
  • Everest lerodalcibep PCSK9 FDA Approval Targets China Launch
  • Cryofocus GERD System Secures NMPA Approval in China
  • Sanofi Adel Alzheimer’s Deal Targets Phase 1 ADEL-Y01 Antibody
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Deals

HBM BMS Multi-Specific Antibody Deal Targets $1 Billion Milestones

Company Drug

Antengene Xpovio sNDA Malaysia Approval Expands DLBCL Indication

Company Drug

Everest lerodalcibep PCSK9 FDA Approval Targets China Launch

Company Medical Device

Cryofocus GERD System Secures NMPA Approval in China

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.